Select Publications

Journal articles

Kava HW; Leung WY; Galea AM; Murray V, 2021, 'The DNA binding properties of 9-aminoacridine carboxamide Pt complexes', Bioorganic and Medicinal Chemistry, 40, http://dx.doi.org/10.1016/j.bmc.2021.116191

Delaney SK; Mills J; Galea A; LeBard RJ; Wilson J; Gibson K; Kornfeld G; Ashraf G, 2017, 'Analysis of Alternative Strategies for the Teaching of Difficult Threshold Concepts in Large Undergraduate Medicine and Science Classes', Medical Science Educator, 27, pp. 673 - 684, http://dx.doi.org/10.1007/s40670-017-0453-x

Murray V; Chen JK; Galea AM, 2014, 'Enhanced DNA repair of bleomycin-induced 3'-phosphoglycolate termini at the transcription start sites of actively transcribed genes in human cells', Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 769, pp. 93 - 99, http://dx.doi.org/10.1016/j.mrfmmm.2014.06.006

Kava HW; Galea AM; Md. Jamil F; Feng Y; Murray V, 2014, 'Characterising the atypical 5′-CG DNA sequence specificity of 9-aminoacridine carboxamide Pt complexes', Journal of Biological Inorganic Chemistry, 19, pp. 997 - 1007, http://dx.doi.org/10.1007/s00775-014-1144-3

Murray V; Chen JK; Galea AM, 2014, 'The anti-tumor drug bleomycin preferentially cleaves at the transcription start sites of actively transcribed genes in human cells', Cellular and Molecular Life Sciences, 71, pp. 1505 - 1512, http://dx.doi.org/10.1007/s00018-013-1456-4

Murray V; Chen JK; Galea AM, 2014, 'The potential of acridine carboxamide Pt complexes as anti-cancer agents: A review', Anti-Cancer Agents in Medicinal Chemistry, 14, pp. 695 - 705, http://dx.doi.org/10.2174/18715206113136660361

Nguyen HT; Galea AM; Murray V, 2013, 'The interaction of cisplatin with a human telomeric DNA sequence containing seventeen tandem repeats', Bioorganic and Medicinal Chemistry Letters, 23, pp. 1041 - 1045, http://dx.doi.org/10.1016/j.bmcl.2012.12.021

Yang H; Sytnyk V; Crossley M; Galea AM, 2012, 'Controlling the size of lipid droplets: Lipid and protein factors', Current Opinion in Cell Biology, 24, pp. 509 - 516, http://dx.doi.org/10.1016/j.ceb.2012.05.012

Murray V; Galea AM, 2012, 'Gene expression profiling of the cancer chemotherapeutic agent, Cisplatin, compared with its ineffective isomer, Transplatin.', Journal of Computer Science and Systems Biology, 5, pp. 37, http://dx.doi.org/10.4172/0974-7230.S1.02

Brown AJ; Galea AM, 2010, 'Cholesterol as an evolutionary response to living with oxygen.', Evolution, 64, pp. 2179 - 2183

Galea AM; Brown AJ, 2009, 'Special relationship between sterols and oxygen: Were sterols an adaptation to aerobic life?', Free Radical Biology and Medicine, 47, pp. 880 - 889

Galea AM; Murray VM, 2008, 'The anti-tumour agent, Cisplatin, and its clinically ineffective isomer, Transplatin, produce unique gene expression profiles in human cells', Cancer Informatics, 6, pp. 315 - 355

Galea AM; Murray V, 2002, 'The interaction of cisplatin and analogues with DNA in reconstituted chromatin', Biochimica et Biophysica Acta - Gene Structure and Expression, 1579, pp. 142 - 152, http://dx.doi.org/10.1016/S0167-4781(02)00535-3

Galea AM; Murray VM, 2002, 'Cisplatin preferentially targets the linker region of the nucleosome', Biochim Biophys ACTA, 1579, pp. 142 - 152

Conference Papers

Murray V; Galea AM, 2009, 'The Unique Gene Expression Profile of the Anti-tumour Agent, Cisplatin, Compared with its Clinically Ineffective Isomer, Transplatin.', in Proceedings of the 2nd International Conference on Biomedical and Pharmaceutical Engineering, IEEE, Singapore, presented at 2nd International Conference on Biomedical and Pharmaceutical Engineering, Singapore, 02 December 2009 - 04 December 2009

Galea AM; Murray VM, 2002, 'Investigating the effect of cisplatin on human gene expression using cDNA microarrays', in Takayama K (ed.), School of Biotechnology and Biomolecular Sciences 1st Annual Symposium, Sydney, presented at School of Biotechnology and Biomolecular Sciences 1st Annual Symposium, Sydney, 08 November 2002

Galea AM; Murray VM, 2002, 'The Interaction of cisplatin with DNA in reconstituted chromatin', in Genome Conference 2001: 22nd Annual Conference on the Organisation and Expression of the Genome, Lorne, Victoria, pp. 44 - 44, presented at Genome Conference 2001: 22nd Annual Conference on the Organisation and Expression of the Genome, Lorne, Victoria, 17 February 2002 - 21 February 2002

Galea AM; Murray VM, 2002, 'Gene expression profiling of human tumour cells using cDNA microarrays: a model test system for anti-tumour drug development', in 2nd Australian Microarray Meeting, Sth Stradbroke Island, Australia, presented at 2nd Australian Microarray Meeting, Sth Stradbroke Island, Australia

Galea AM; Murray VM, 2002, 'The interaction of anti-tumour agents with nucleosomal core DNA in reconstituted chromatin', in ComBio Conference, Sydney, presented at ComBio Conference, Sydney

Theses / Dissertations

Galea AM, 2006, Investigating the mechanism of action of the chemotherapeutic agent, cisplatin: drug-DNA interactions in reconstituted chromatin and human gene expression profiling.


Back to profile page